Image Credit :https://www.psychiatryadvisor.com/home/bipolar-disorder-advisor/presence-of-psychosis-in-bipolar-depression-not-a-factor-in-treatment-outcomes/
Schizophrenia is associated with risk factors for poor outcomes with SARS-CoV-2/coronavirus disease 2019 (COVID-19) infection, including diabetes, hypertension, and chronic obstructive pulmonary disease (COPD). A recent study found that schizophrenia was associated with an increased risk of severe COVID-19 infection. Whether health outcomes and care differ between patients with COVID-19 with (versus without) comorbid schizophrenia remains unclear. Fond and colleagues2 compared in-hospital mortality and intensive care unit (ICU) admissions between patients with schizophrenia and those without a diagnosis of severe mental illness in a French population-based cohort study.
People with severe mental illness (SMI) are a vulnerable population. In the context of COVID-19, there is reason to suspect they may be at increased risk of contracting SARS-CoV-2 and have worse outcomes following infection, however we found no existing data that quantified these risks. Public health measures associated with COVID-19, including quarantine of suspected cases and lockdowns may negatively affect the mental health status of people with SMI, through change of environment, disruption of services, increased stress and isolation. Existing research points to greater psychological distress during the pandemic for people with SMI, rather than demonstrating this distress is due to the pandemic. The authors concluded that this is the largest series of patients with schizophrenia and COVID-19 to date. They found evidence for the existence of disparities in health and health care between patients with versus without schizophrenia, including increased in-hospital mortality and decreased ICU admission. Study limitations include the absence of data on the time between onset of infection and hospitalization, psychotropic medication, and the use of anti-COVID-19 treatments. Nevertheless, findings suggest the importance of health care strategies before, during, and after hospitalization for reducing health disparities in this vulnerable population
Normally, younger patients with schizophrenia who smoke, are obese, and have COPD are at heightened risk for poor outcomes with COVID-19 infection and should be targeted for early intervention.
Coronavirus disease (COVID-19) has caused by severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), has affected over more than 48 % world population and has led to deaths of more than 140000 people. It is becoming a major concern for all health systems.
Among the effects of this virus one of the other ways it is affecting ourselves is the mental health of people who have tend to fall in different types of mental health issues such as psychosis, depression , stress anxiety, bipolar etc.
As we know Bipolar disorder is an illness that involves mood swings with at least one episode of mania and may also involve repeated episodes of depression. Schizophrenia is a chronic, severe, debilitating mental illness characterized by psychotic symptoms, meaning that one is out of touch with reality.
Due to virus and lock down situation it has made it very difficult to have some outside activities and have also triggered the patients of bipolar and schizophrenia especially which has caused in their relapsing from recovery.
The next thing if you find people around you suffering from any kind of mental health issues such as bipolar , schizophrenia, psychosis etc kindly reach us via Call/Whatsapp +60146872268 or visit our website www.sereneretreat.com.my for more information.
11, Jalan Setiakasih 9, Bukit Damansara, 50490 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur